Skip to main content
Natural Capsules Ltd. logo

Natural Capsules Ltd. — Investor Relations & Filings

Ticker · NATCAPSUQ ISIN · INE936B01015 LEI · 335800JVYFZWBNKMS446 BSE.NS Manufacturing
Filings indexed 86 across all filing types
Latest filing 2025-12-06 Regulatory Filings
Country IN India
Listing BSE.NS NATCAPSUQ

About Natural Capsules Ltd.

https://www.naturalcapsules.com

Natural Capsules Ltd. is a specialized manufacturer of hard capsules catering to the pharmaceutical and nutraceutical sectors. The company produces a wide range of products, including hard gelatin capsules and vegetarian alternatives such as HPMC (Hydroxypropyl Methylcellulose) capsules. Its manufacturing capabilities extend to specialized variants like liquid-fill capsules and preservative-free options. The company emphasizes adherence to international quality standards and Good Manufacturing Practices (GMP) to ensure product safety and efficacy. By leveraging advanced technology in capsule shell production, it serves a global clientele of pharmaceutical formulators and dietary supplement providers. The core focus remains on providing high-quality delivery systems for oral dosage forms, supporting diverse therapeutic and nutritional applications.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2025-12-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on November 17, 2025, discussing the Q2 and H1 FY'26 earnings of Natural Capsules Limited. It includes detailed management commentary on financial performance, operational challenges, guidance, and a Q&A session with analysts. The text explicitly mentions it is a transcript of the earnings conference call, which is a typical format for Call Transcripts (CT). The document contains substantive discussion of financial results and outlook but is not itself a formal earnings release or financial report. Therefore, the correct classification is Call Transcript (CT).
2025-11-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the availability of an audio recording of a conference call held on November 17, 2025. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides a link to the audio recording on the company's website. The document does not contain the transcript or detailed content of the call itself, only an announcement that the recording is available. The document length is short (1759 characters), and it serves as a notification rather than the full transcript or detailed financial data. Therefore, it is not a Call Transcript (CT) but rather a Regulatory Filing (RNS) announcing the availability of the conference call recording.
2025-11-17 English
Copy of Newspaper Publication
Regulatory Filings
2025-11-15 English
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is a press release announcing the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. It includes financial highlights such as revenue, PAT, EBITDA, EPS, and margins for Q2 and H1 FY26. There is commentary from the Executive Director on business performance and challenges. The document is addressed to stock exchanges and references compliance with SEBI regulations. The length is about 6,497 characters, which is sufficient to contain substantive financial data and analysis, not just a brief announcement or a link to a report. Therefore, this document is a quarterly/interim financial report containing actual financial results and management commentary for a period shorter than a full fiscal year. Hence, it fits the definition of an Interim / Quarterly Report (IR).
2025-11-14 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation' and is addressed to stock exchanges pursuant to SEBI regulations, indicating it is a formal investor communication. It contains detailed financial data for the quarter and half year ended 30th September 2025, including revenue, EBITDA, profit and loss, balance sheet, and cash flow summaries. It also includes management commentary, business overview, company history, product offerings, and global presence. The length is about 15,000 characters, which is consistent with a detailed presentation rather than a brief announcement. The content focuses on financial performance, business strategy, and market position, typical of an investor presentation. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is not a regulatory filing or announcement of a report publication. Therefore, the document fits the definition of an Investor Presentation (IP).
2025-11-14 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.